晚期慢性肾脏病老年患者临终前的临床与患者报告结局轨迹
EQUAL 研究纳入 661 例 eGFR<20 ml/min/1.73 m² 且≥65 岁的晚期 CKD 患者,分析死亡前 4 年临床指标、患者报告结局与住院率的纵向轨迹。结果显示多项生理指标在死亡前 6~12 个月出现加速下降,症状数量在死亡前 1 年加速增加,住院率在死亡前 6 个月指数上升。
要点
- eGFR、主观全面评估评分和血压在死亡前 6 个月出现加速下降。
- 血红蛋白、红细胞压积、胆固醇、钙、白蛋白和钠在死亡前 6~12 个月加速下降。
- 住院率在死亡前 6 个月指数上升,症状数量在死亡前 1 年加速增加。
核心结论
- 患者轨迹中存在临床相关的生理性加速,始于死亡前约 6~12 个月,可能为多因素所致,但与住院率激增相关。
研究设计与样本
- EQUAL 研究为欧洲观察性前瞻性队列研究,纳入 eGFR<20 ml/min/1.73 m² 且年龄≥65 岁的患者。
- 共纳入 661 例死亡患者,至死亡的中位时间为 2.0 年(IQR 0.9-3.2)。
- 使用广义相加模型分析死亡前 4 年各临床指标的演变。
主要发现
- 死亡前数年 eGFR、主观全面评估评分和血压下降,死亡前 6 个月出现加速。
- 血清血红蛋白、红细胞压积、胆固醇、钙、白蛋白和钠在随访期间缓慢下降,死亡前 6~12 个月出现加速。
- 躯体和心理生活质量在整个随访期间呈线性下降。
- 报告的症状数量至死亡前 2 年保持稳定,死亡前 1 年出现加速增加。
- 住院率稳定在约每人年 1 次住院,死亡前 6 个月呈指数上升。
临床怎么用
- 作者认为进一步研究应关注如何有效利用这些知识来引导患者和家属的预期、有益于(临终)照护的规划,并建立临床预警系统。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We explore longitudinal trajectories of clinical indicators, patient-reported outcomes, and hospitalizations, in the years preceding death in a population of older patients with advanced chronic kidney disease (CKD). METHODS: The EQUAL study is a European observational prospective cohort study with an incident eGFR <20 ml/min per 1.73 m2 and ≥65 years of age. The evolution of each clinical indicator was explored using generalized additive models during the 4 years preceding death. RESULTS: We included 661 decedents with a median time to death of 2.0 years (IQR 0.9-3.2). During the years preceding death, eGFR, Subjective Global Assessment score, and blood pressure declined, with accelerations seen at 6 months preceding death. Serum hemoglobin, hematocrit, cholesterol, calcium, albumin, and sodium values declined slowly during follow-up, with accelerations observed between 6 and 12 months preceding death. Physical and mental quality of life declined linearly throughout follow-up. The number of reported symptoms was stable up to 2 years prior to death, with an acceleration observed at 1 year prior to death. The rate of hospitalization was stable at around one hospitalization per person year, increasing exponentially at 6 months preceding death. CONCLUSIONS: We identified clinically relevant physiological accelerations in patient trajectories that began ∼6 to 12 months prior to death, which are likely multifactorial in nature, but correlate with a surge in hospitalizations. Further research should focus on how to effectively use this knowledge to inform patient and family expectations, to benefit the planning of (end-of-life) care, and to establish clinical alert systems.
引用
- Chesnaye NC, Caskey FJ, Dekker FW, et al. Clinical and patient-reported trajectories at end-of-life in older patients with advanced CKD. Nephrol Dial Transplant. 2023. PMID: 37193666. doi:10.1093/ndt/gfad091
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。